Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) just unveiled an update.
Shandong Xinhua Pharmaceutical Company Limited has announced a final cash dividend of RMB 0.25 per share for the financial year ending December 31, 2024. The announcement reflects the company’s financial performance and commitment to returning value to shareholders, although specific details regarding the payment date and withholding tax are yet to be disclosed.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is listed on the Hong Kong Stock Exchange and engages in manufacturing a range of pharmaceutical goods.
YTD Price Performance: -0.69%
Average Trading Volume: 3,436,257
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$9.16B
Learn more about 0719 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue